SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 61 filers reported holding SPERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $93,363 | +6.0% | 64,388 | +26.5% | 0.00% | – |
Q4 2022 | $88,087 | -76.4% | 50,917 | -72.7% | 0.00% | -100.0% |
Q3 2022 | $374,000 | +1285.2% | 186,570 | +413.0% | 0.00% | – |
Q2 2022 | $27,000 | -88.1% | 36,369 | +39.7% | 0.00% | – |
Q1 2022 | $227,000 | +11.3% | 26,027 | +47.1% | 0.00% | -100.0% |
Q2 2019 | $204,000 | +161.5% | 17,699 | +187.9% | 0.00% | – |
Q1 2019 | $78,000 | – | 6,148 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 3,932,209 | $76,246,000 | 15.85% |
Atlas Venture Associates XI, LLC | 1,376,968 | $26,700,000 | 4.23% |
Atlas Venture Associates IX, LLC | 1,376,968 | $26,700,000 | 4.23% |
BVF INC/IL | 2,243,278 | $43,497,000 | 1.71% |
AWM Investment Company, Inc. | 372,755 | $7,228,000 | 0.92% |
Alphabet Inc. | 889,979 | $17,257,000 | 0.83% |
Rock Springs Capital Management LP | 1,235,000 | $23,947,000 | 0.51% |
Novo Holdings A/S | 576,702 | $11,182,000 | 0.48% |
Artal Group S.A. | 500,000 | $9,695,000 | 0.21% |
Granahan Investment Management | 420,320 | $8,150,000 | 0.18% |